The
factors affecting the formation and crystal structures of unusual
6d1 Th(III) square planar aryloxide complexes, as exemplified
by [Th(OArMe)4]1– (OArMe = OC6H2
t
Bu2-2,6-Me-4), were explored by synthetic and reduction
studies of a series of related Th(IV) tetrakis(aryloxide) complexes,
Th(OArR)4 (OArR = OC6H2
t
Bu2-2,6-R-4). Specifically,
electronic, steric, and countercation effects were explored by varying
the aryloxide ligand, the alkali metal reducing agent, and the alkali
metal chelating agent. Salt metathesis reactions between ThBr4(DME)2 (DME = 1,2-dimethoxyethane) and 4 equiv
of the appropriate potassium aryloxide salt were used to prepare a
series of Th(IV) aryloxide complexes in high yields: Th(OArH)4 (OArH = OC6H3
t
Bu2-2,6), Th(OArtBu)4 (OArtBu = OC6H2
t
Bu3-2,4,6), Th(OArOMe)4 (OArOMe = OC6H2
t
Bu2-2,6-OMe-4), and Th(OArPh)4 (OArPh = OC6H2
t
Bu2-2,6-Ph-4). Th(OArH)4 can be reduced by KC8, Na, or Li
in the absence or presence of 2.2.2-cryptand (crypt) or 18-crown-6
(crown) to form dark purple solutions that have EPR and UV–visible
spectra similar to those of the square planar Th(III) complex, [Th(OArMe)4]1–. Hence, the para position of the aryloxide ligand does not have to be alkylated to
obtain the Th(III) complexes. Furthermore, reduction of Th(OArOMe)4, Th(OArtBu)4, and Th(OArPh)4 with KC8 in THF generated purple
solutions with EPR and UV–visible spectra that are similar
to those of the previously reported Th(III) anion, [Th(OArMe)4]1–. Although many of these reduction
reactions did not produce single crystals suitable for study by X-ray
diffraction, reduction of Th(OArH)4, Th(OArtBu)4, and Th(OArOMe)4 with
Li provided X-ray quality crystals whose structures had square planar
coordination geometries. Reduction of Th(OArPh)4 with Li also gave a product with EPR and UV–visible spectra
that matched those of [Th(OArMe)4]1–, but X-ray quality crystals of the reduction product were too unstable
to provide data. Neither Th(Odipp)4(THF)2 (Odipp
= OC6H3
i
Pr2-2,6) nor Th(Odmp)4(THF)2 (Odmp = OC6H3Me2-2,6) could be reduced to Th(III) products
under similar conditions. Reduction of U(OArH)3(THF) with KC8 in the presence of 2.2.2-cryptand (crypt)
was examined for comparison and formed [K(crypt)][U(OArH)4], which has a tetrahedral arrangement of the aryloxide
ligands. Moreover, no further reduction was observed when either [K(crypt)][U(OArH)4] or [K(crown)(THF)2][U(OArH)4] were treated with KC8 or Li.